Immune-related saliva micro-RNA’s to predict clinical response to a combination of cetuximab and low-dose chemotherapy in head and neck cancer (HNSCC) patients (pts) with poor performance status (PS).

In collaboration with IIT Delhi, AIIMS has developed a cost-effective prosthesis for patients with throat cancer who have lost their ability to speak. The prosthesis is placed through the ...